UnitedHealth Group (NYSE:UNH) – Equities research analysts at Jefferies Group increased their Q2 2018 earnings per share estimates for shares of UnitedHealth Group in a report released on Tuesday, April 17th. Jefferies Group analyst D. Windley now anticipates that the healthcare conglomerate will earn $3.01 per share for the quarter, up from their prior estimate of $2.97. Jefferies Group also issued estimates for UnitedHealth Group’s Q3 2018 earnings at $3.34 EPS, Q4 2018 earnings at $3.22 EPS, FY2018 earnings at $12.61 EPS and FY2019 earnings at $14.50 EPS.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 17th. The healthcare conglomerate reported $3.04 EPS for the quarter, beating the Zacks’ consensus estimate of $2.91 by $0.13. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company had revenue of $55.19 billion for the quarter, compared to the consensus estimate of $54.90 billion. During the same period in the prior year, the firm posted $2.37 EPS. The company’s quarterly revenue was up 13.3% compared to the same quarter last year.
Other equities research analysts also recently issued reports about the stock. Deutsche Bank increased their price objective on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Sanford C. Bernstein set a $275.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Wednesday. Royal Bank of Canada restated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday. Piper Jaffray restated a “buy” rating and issued a $270.00 target price on shares of UnitedHealth Group in a report on Wednesday. Finally, Oppenheimer upped their target price on shares of UnitedHealth Group from $260.00 to $276.00 and gave the company an “outperform” rating in a report on Wednesday. Three analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $251.13.
Shares of NYSE:UNH opened at $236.40 on Thursday. UnitedHealth Group has a 52 week low of $166.65 and a 52 week high of $250.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $222,872.13, a price-to-earnings ratio of 23.48, a PEG ratio of 1.34 and a beta of 0.77.
A number of institutional investors have recently made changes to their positions in UNH. Exane Derivatives raised its position in UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after buying an additional 460 shares during the last quarter. Aevitas Wealth Management Inc. purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $102,000. Pathstone Family Office LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $129,000. Trustcore Financial Services LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $133,000. Finally, Intellectus Partners LLC increased its holdings in shares of UnitedHealth Group by 18.2% in the 2nd quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock valued at $152,000 after purchasing an additional 126 shares in the last quarter. Institutional investors own 86.78% of the company’s stock.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction on Friday, January 19th. The shares were sold at an average price of $242.55, for a total transaction of $48,024.90. Following the completion of the transaction, the director now owns 1,790,567 shares in the company, valued at approximately $434,302,025.85. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Larry C. Renfro sold 22,184 shares of the company’s stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the transaction, the insider now owns 173,229 shares of the company’s stock, valued at approximately $39,659,047.26. The disclosure for this sale can be found here. In the last quarter, insiders have sold 77,015 shares of company stock valued at $17,879,199. 0.89% of the stock is owned by company insiders.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 20th. Investors of record on Friday, March 9th were paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.27%. The ex-dividend date was Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 29.79%.
COPYRIGHT VIOLATION WARNING: This news story was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://ledgergazette.com/2018/04/19/jefferies-group-comments-on-unitedhealth-groups-q2-2018-earnings-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.